Position in ARVN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$324,264
New position
Shares Held
30,591
first reported quarter
Ownership
0.047%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 2026VARCOV Co. holds $10,399,067 across 30 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | SMMT |
Summit Therapeutics Inc.
|
63,957 | $931,853 | |
| 2 | TARS |
Tarsus Pharmaceuticals, Inc.
|
13,057 | $821,807 | |
| 3 | MDGL |
Madrigal Pharmaceuticals, Inc.
|
1,018 | $546,615 | |
| 4 | VKTX |
Viking Therapeutics, Inc.
|
13,926 | $543,253 | |
| 5 | RAPP |
Rapport Therapeutics, Inc.
|
12,895 | $537,334 | |
| 6 | IONS |
Ionis Pharmaceuticals Inc
|
5,390 | $427,373 | |
| 7 | SRRK |
Scholar Rock Holding Corp
|
7,530 | $414,150 | |
| 8 | CELC |
Celcuity Inc.
|
3,732 | $390,441 |
All Filings in ARVN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $324,264 | 30,591 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||